Table 5 Association of 2-h plasma glucose during OGTT (square root-transformed) with CVD mortality.

From: Postprandial 2-h glucose tolerance is associated with diabetes diagnosis, diabetes mortality, and cardiovascular mortality

Models

2-h PGOGTT@4–7.9 h

2-h PGOGTT@fasting

HR

95% CI

p

HR

95% CI

p

Model 1

1.13

1.10–1.17

< 0.001

1.12

1.10–1.15

< 0.001

Model 2

1.08

1.05–1.12

< 0.001

1.07

1.05–1.10

< 0.001

Model 3

1.07

1.04–1.11

< 0.001

1.07

1.04–1.10

< 0.001

Model 4

1.08

1.05–1.12

< 0.001

1.08

1.05–1.10

< 0.001

Model 5

1.07

1.03–1.11

< 0.001

1.06

1.03–1.09

< 0.001

Model 6

1.07

1.03–1.11

< 0.001

1.06

1.03–1.09

< 0.001

  1. 2-h PGOGTT@4–7.9 h, 2-hour plasma glucose during OGTT which was conducted in the postprandial period between 4 and 7.9 h; 2-h PGOGTT@fasting, 2-hour plasma glucose during OGTT which was conducted in the fasting period (fasting time, ≥ 8 h); CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; OGTT, oral glucose tolerance test.
  2. Model 1 was not adjusted; Model 2 was adjusted for age, sex, and ethnicity; Model 3 was adjusted for all the factors in Model 2 plus body mass index, poverty–income ratio, and education; Model 4 was adjusted for all the factors in Model 3 plus physical activity, alcohol consumption, smoking status, and survey period; Model 5 was adjusted for all the factors in Model 4 plus total cholesterol, HDL cholesterol, and systolic blood pressure; and Model 6 was adjusted for all the factors in Model 5 plus family history of diabetes.
Back to article page